HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
British Journal of Cancer 115, 725 (06 September 2016). doi:10.1038/bjc.2016.247
Authors: Anne Ørbo, Marit Arnes, Lena Myreng Lyså, Christer Borgfelt & Bjørn Straume
from Cancer via ola Kala on Inoreader http://ift.tt/2cCvNms
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου